L-Tartaric acid → HCID 49856396, compound
Reaction equation
[N:1]1([C:6]2[CH:7]=[C:8]3[C:13](=[CH:14][CH:15]=2)[N:12]=[C:11]([C:16]2[CH:21]=[CH:20][CH:19]=[CH:18][CH:17]=2)[N:10]=[CH:9]3)[CH:5]=[CH:4][N:3]=[CH:2]1.[C:22]([OH:31])(=[O:30])[C@@H:23]([C@H:25]([C:27]([OH:29])=[O:28])[OH:26])[OH:24]>C(#N)C>[C:27]([C@@H:25]([C@H:23]([C:22]([OH:31])=[O:30])[OH:24])[OH:26])([OH:29])=[O:28].[N:1]1([C:6]2[CH:7]=[C:8]3[C:13](=[CH:14][CH:15]=2)[N:12]=[C:11]([C:16]2[CH:21]=[CH:20][CH:19]=[CH:18][CH:17]=2)[N:10]=[CH:9]3)[CH:5]=[CH:4][N:3]=[CH:2]1Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Conditions
- Temperature
- 0 °C
Procedure
6-(1H-Imidazol-1-yl)-2-phenylquinazoline, 50 mg (0.18 mmol), is suspended in 4 mL of acetonitrile, the mixture is then heated at reflux and 30 mg of L-tartaric acid are added, the suspension is heated at reflux for a further 30 min, it is filtered and then cooled to 0° C., and the resulting suspension is stirred at 25° C. for three days and then filtered and dried at 20° C., 20 mmHg, for 12 hours. 30 mg of product are obtained in the form of yellow crystals, KF=14.67%, Calculated for C17H12N4.C4H6O6.4H2O: C, 51.01; H, 5.30; N, 11.33. found: C, 50.64; H, 5.41; N, 11.28. XRPD form B. Form B heated at 40° C., 85% RH for 7 days is stable (XRPD), but gives rise to the amorphous form when heated at 90° C. for 12 hours.